Intravesicular epidermal growth factor receptor subject to retrograde trafficking drives epidermal growth factor-dependent migration

Sabrina Maisel, Derrick Broka, Joyce Schroeder

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The Epidermal Growth Factor Receptor (EGFR) is frequently mutated and overexpressed in metastatic cancer. Although EGFR is a transmembrane tyrosine kinase localized to the basolateral membrane in normal epithelium, it is frequently found intracellularly localized in transformed cells. We have previously demonstrated the epithelial adaptor protein mucin 1 (MUC1) alters trafficking of EGFR, inhibiting its degradation and promoting its translocation to the nucleus, where it can directly modulate gene transcription. Here, we demonstrate that MUC1 promotes the retention of EGF-bound EGFR in Early Endosome Antigen1 (EEA1)-positive vesicles while preventing its trafficking to the lysosome. These events result in the accumulation of endosomal vesicles harboring active receptor throughout the cell and a reorganization of the actin cytoskeleton. EGF-dependent cell migration and filopodia formation is reliant upon this altered trafficking, and can be prevented by blocking retrograde trafficking. Together, these results indicate that intracellular EGFR may play an essential role in cancer metastasis and a potential mechanism for the failure of therapeutic antibodies in EGFR-driven metastatic breast cancer.

Original languageEnglish (US)
Pages (from-to)6463-6477
Number of pages15
JournalOncotarget
Volume9
Issue number5
DOIs
StatePublished - Jan 1 2018

Fingerprint

Epidermal Growth Factor Receptor
Epidermal Growth Factor
Mucin-1
Pseudopodia
Endosomes
Lysosomes
Actin Cytoskeleton
Protein-Tyrosine Kinases
Cell Movement
Neoplasms
Epithelium
Breast Neoplasms
Neoplasm Metastasis
Membranes
Antibodies
Genes
Proteins

Keywords

  • Cetuximab
  • Epidermal growth factor receptor
  • Migration
  • MUC1
  • Retrograde trafficking

ASJC Scopus subject areas

  • Oncology

Cite this

Intravesicular epidermal growth factor receptor subject to retrograde trafficking drives epidermal growth factor-dependent migration. / Maisel, Sabrina; Broka, Derrick; Schroeder, Joyce.

In: Oncotarget, Vol. 9, No. 5, 01.01.2018, p. 6463-6477.

Research output: Contribution to journalArticle

@article{aa54363fe29a4c629443ae01bbcc09eb,
title = "Intravesicular epidermal growth factor receptor subject to retrograde trafficking drives epidermal growth factor-dependent migration",
abstract = "The Epidermal Growth Factor Receptor (EGFR) is frequently mutated and overexpressed in metastatic cancer. Although EGFR is a transmembrane tyrosine kinase localized to the basolateral membrane in normal epithelium, it is frequently found intracellularly localized in transformed cells. We have previously demonstrated the epithelial adaptor protein mucin 1 (MUC1) alters trafficking of EGFR, inhibiting its degradation and promoting its translocation to the nucleus, where it can directly modulate gene transcription. Here, we demonstrate that MUC1 promotes the retention of EGF-bound EGFR in Early Endosome Antigen1 (EEA1)-positive vesicles while preventing its trafficking to the lysosome. These events result in the accumulation of endosomal vesicles harboring active receptor throughout the cell and a reorganization of the actin cytoskeleton. EGF-dependent cell migration and filopodia formation is reliant upon this altered trafficking, and can be prevented by blocking retrograde trafficking. Together, these results indicate that intracellular EGFR may play an essential role in cancer metastasis and a potential mechanism for the failure of therapeutic antibodies in EGFR-driven metastatic breast cancer.",
keywords = "Cetuximab, Epidermal growth factor receptor, Migration, MUC1, Retrograde trafficking",
author = "Sabrina Maisel and Derrick Broka and Joyce Schroeder",
year = "2018",
month = "1",
day = "1",
doi = "10.18632/oncotarget.23766",
language = "English (US)",
volume = "9",
pages = "6463--6477",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "5",

}

TY - JOUR

T1 - Intravesicular epidermal growth factor receptor subject to retrograde trafficking drives epidermal growth factor-dependent migration

AU - Maisel, Sabrina

AU - Broka, Derrick

AU - Schroeder, Joyce

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The Epidermal Growth Factor Receptor (EGFR) is frequently mutated and overexpressed in metastatic cancer. Although EGFR is a transmembrane tyrosine kinase localized to the basolateral membrane in normal epithelium, it is frequently found intracellularly localized in transformed cells. We have previously demonstrated the epithelial adaptor protein mucin 1 (MUC1) alters trafficking of EGFR, inhibiting its degradation and promoting its translocation to the nucleus, where it can directly modulate gene transcription. Here, we demonstrate that MUC1 promotes the retention of EGF-bound EGFR in Early Endosome Antigen1 (EEA1)-positive vesicles while preventing its trafficking to the lysosome. These events result in the accumulation of endosomal vesicles harboring active receptor throughout the cell and a reorganization of the actin cytoskeleton. EGF-dependent cell migration and filopodia formation is reliant upon this altered trafficking, and can be prevented by blocking retrograde trafficking. Together, these results indicate that intracellular EGFR may play an essential role in cancer metastasis and a potential mechanism for the failure of therapeutic antibodies in EGFR-driven metastatic breast cancer.

AB - The Epidermal Growth Factor Receptor (EGFR) is frequently mutated and overexpressed in metastatic cancer. Although EGFR is a transmembrane tyrosine kinase localized to the basolateral membrane in normal epithelium, it is frequently found intracellularly localized in transformed cells. We have previously demonstrated the epithelial adaptor protein mucin 1 (MUC1) alters trafficking of EGFR, inhibiting its degradation and promoting its translocation to the nucleus, where it can directly modulate gene transcription. Here, we demonstrate that MUC1 promotes the retention of EGF-bound EGFR in Early Endosome Antigen1 (EEA1)-positive vesicles while preventing its trafficking to the lysosome. These events result in the accumulation of endosomal vesicles harboring active receptor throughout the cell and a reorganization of the actin cytoskeleton. EGF-dependent cell migration and filopodia formation is reliant upon this altered trafficking, and can be prevented by blocking retrograde trafficking. Together, these results indicate that intracellular EGFR may play an essential role in cancer metastasis and a potential mechanism for the failure of therapeutic antibodies in EGFR-driven metastatic breast cancer.

KW - Cetuximab

KW - Epidermal growth factor receptor

KW - Migration

KW - MUC1

KW - Retrograde trafficking

UR - http://www.scopus.com/inward/record.url?scp=85040672122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040672122&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.23766

DO - 10.18632/oncotarget.23766

M3 - Article

AN - SCOPUS:85040672122

VL - 9

SP - 6463

EP - 6477

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 5

ER -